-
Graft Versus Host Disease and Transplant Complications
6012552
global
1
0.5
0.5
Clinical Review
0
1
Hematology-Oncology2023-09-28 20:00:00
Are you up to date on recent advances in GvHD prevention and treatment?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Lung Cancer
5000186
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-09-24 20:00:00
Providing individualized care for patients with lung cancer
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Ovarian Cancer
839
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-09-19 20:00:00
Do you know which biomarkers can help you identify patients with advanced ovarian cancer (OC) who may benefit most from first-line maintenance with a poly(ADP-ribose) polymerase (PARP) inhibitor?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Prostate Cancer
3003438
global
1
0.75
9
0.75
0.75
Commentary
0
1
Hematology-Oncology2023-08-23 20:00:00
Are you up to date on the latest data on novel therapies being explored for patients with advanced prostate cancer?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Palliative Care
3029326
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-08-08 20:00:00
Giving therapeutic guidance to patients is difficult. Shared decision-making builds trust to support optimal outcomes when treatment isn't an option.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
0.25
9
0.25
0.25
Clinical Case
0
1
Hematology-Oncology2023-08-06 20:00:00
Did you know there are emerging treatment approaches demonstrating efficacy in refractory EGFR-mutated NSCLC?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Graft Versus Host Disease and Transplant Complications
6012552
global
1
0.5
0.5
Clinical Review
0
1
Hematology-Oncology2023-09-28 20:00:00
Are you up to date on recent advances in GvHD prevention and treatment?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Revenue and Practice Management
3029345
global
1
0.5
9
0.5
2
0.5
3
0.5
8
0.5
0.5
Clinical Brief
0
1
Family Medicine/Primary Care2023-09-29 00:00:00
Learn about the latest developments in family medicine: alopecia areata, glaucoma, and breast cancer.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Lung Cancer
5000186
global
1
1.0
9
1.0
1.0
Clinical Case
0
1
Hematology-Oncology2023-09-24 20:00:00
Providing individualized care for patients with lung cancer
1.0ABIM MOC
1.0CME/CE
60MIN
Save
-
Ovarian Cancer
839
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-09-19 20:00:00
Do you know which biomarkers can help you identify patients with advanced ovarian cancer (OC) who may benefit most from first-line maintenance with a poly(ADP-ribose) polymerase (PARP) inhibitor?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Colorectal Cancer
3032296
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Review
0
2
Hematology-Oncology2023-09-20 00:00:00
Did you know that there is strong evidence that screening for colorectal cancer (CRC) reduces incidence and mortality?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Non-Alcoholic Fatty Liver Disease
5000208
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
2
Gastroenterology2023-08-25 00:00:00
New ADA Standards of Care promote broad changes in the management of Nonalcoholic Fatty Liver Disease.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Prostate Cancer
3003438
global
1
0.75
9
0.75
0.75
Commentary
0
1
Hematology-Oncology2023-08-23 20:00:00
Are you up to date on the latest data on novel therapies being explored for patients with advanced prostate cancer?
0.75ABIM MOC
0.75CME/CE
45MIN
Save
-
Palliative Care
3029326
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-08-08 20:00:00
Giving therapeutic guidance to patients is difficult. Shared decision-making builds trust to support optimal outcomes when treatment isn't an option.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Non-Small Cell Lung Cancer
3004986
global
1
0.25
9
0.25
0.25
Clinical Case
0
1
Hematology-Oncology2023-08-06 20:00:00
Did you know there are emerging treatment approaches demonstrating efficacy in refractory EGFR-mutated NSCLC?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Skin Cancer
56
global
1
0.25
9
0.25
2
0.25
3
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-08-01 20:00:00
Did you know that BRAF class II/III alterations comprise more than half of oncogenic BRAF alterations?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
0
global
1
0.25
9
0.25
0.25
Commentary
0
1
Hematology-Oncology2023-07-30 20:00:00
Did you know the majority of patients with biliary tract cancer have advanced disease at diagnosis?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
0
global
1
0.5
9
0.5
2
0.5
3
0.5
0.5
Commentary
0
1
Pathology & Lab Medicine2023-07-30 20:00:00
Stay current with this critical discussion on epidermal growth factor receptor (EGFR) exon 20 testing and treatment in non-small cell lung cancer (NSCLC).
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
Breast Cancer
840
global
1
0.25
9
0.25
0.25
Clinical Review
0
1
Hematology-Oncology2023-07-27 20:00:00
How well do you know the latest data on oral selective estrogen receptor degraders (SERDs)?
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Breast Cancer
840
global
1
0.25
9
0.25
2
0.25
3
0.25
8
0.25
0.25
Clinical Brief
0
1
Hematology-Oncology2023-07-14 00:00:00
USPSTF breast cancer screening guidance updated, based on new evidence on incidence and racial disparities.
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Myelodysplastic Syndrome
1557
global
1
0.5
9
0.5
0.5
Clinical Review
0
1
Hematology-Oncology2023-07-02 20:00:00
What's the latest in lower-risk myelodysplastic syndrome (LR-MDS) management? Join as Dr Komrokji summarizes the latest data.
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
0
global
1
0.5
9
0.5
0.5
Roundtable
0
1
Hematology-Oncology2023-07-02 20:00:00
Do you know the most common treatment-related adverse events of the 3 trophoblast cell surface antigen 2 (TROP2)-targeting antibody-drug conjugates (ADCs) furthest along in development?
0.5ABIM MOC
0.5CME/CE
30MIN
Save
-
COVID-19
6012524
global
1
0.25
9
0.25
2
0.25
8
0.25
0.25
Clinical Brief
0
1
Infectious Diseases2023-06-29 20:00:00
Find out what factors impact the incidence of long COVID
0.25ABIM MOC
0.25CME/CE
15MIN
Save
-
Multiple Myeloma
1166
global
2
1.5
1.5
Clinical Review
0
1
Hematology-Oncology2023-06-29 20:00:00
Discover groundbreaking MOAs, enhance shared decision making and tackle disparities. Four expert nurses offer clinical pearls and practical solutions.
1.5ABIM MOC
1.5CME/CE
90MIN
Save
